pyrrolidines - Ontology Report - Rat Genome Database

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	pyrrolidines	go back to main search page
Accession:	CHEBI:38260	browse the term
Definition:	Any of a class of heterocyclic amines having a saturated five-membered ring.
Synonyms:	alt_id:	CHEBI:26922; CHEBI:38191

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

(S)-nicotine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Aatk	apoptosis-associated tyrosine kinase		increases expression	ISO	10	109,419,819	109,456,182	RGD:6480464	CTD
G	Abcg2	ATP-binding cassette, subfamily G (WHITE), member 2		increases expression	ISO	4	87,502,584	87,560,017	RGD:6480464	CTD
G	Acaca	acetyl-CoA carboxylase alpha		multiple interactions	ISO	10	72,483,772	72,677,134	RGD:6480464	CTD
G	Ace	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1		increases expression	ISO	10	95,361,338	95,381,455	RGD:6480464	CTD
G	Ache	acetylcholinesterase		decreases activity	EXP				RGD:6480464	CTD
G	Ache	acetylcholinesterase		increases activity	EXP				RGD:6480464	CTD
G	Acta1	actin, alpha 1, skeletal muscle		increases expression	ISO	19	54,081,496	54,084,508	RGD:6480464	CTD
G	Actb	actin, beta		increases expression	ISO	12	12,047,070	12,050,040	RGD:6480464	CTD
G	Adk	adenosine kinase		increases expression	ISO	15	3,071,412	3,458,891	RGD:6480464	CTD
G	Adm2	adrenomedullin 2		multiple interactions	EXP	7	127,620,056	127,621,802	RGD:6480464	CTD
G	Ak3	adenylate kinase 3		increases expression	ISO	1	232,658,879	232,684,083	RGD:6480464	CTD
G	Ak5	adenylate kinase 5		increases expression	ISO				RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		increases expression	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		increases phosphorylation	EXP	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Alad	aminolevulinate dehydratase		decreases activity	ISO	5	79,505,645	79,515,983	RGD:6480464	CTD
G	Alox12	arachidonate 12-lipoxygenase		increases expression	ISO	10	57,080,603	57,092,874	RGD:6480464	CTD
G	Alox12e	arachidonate 12-lipoxygenase, epidermal		increases expression	ISO	10	57,159,920	57,167,385	RGD:6480464	CTD
G	Alox5	arachidonate 5-lipoxygenase		multiple interactions	ISO	4	152,610,283	152,657,891	RGD:6480464	CTD
G	Alox5	arachidonate 5-lipoxygenase		multiple interactions	ISO	4	152,610,283	152,657,891	RGD:6480464	CTD
G	Alox5	arachidonate 5-lipoxygenase		increases expression	ISO	4	152,610,283	152,657,891	RGD:6480464	CTD
G	Alox5	arachidonate 5-lipoxygenase		increases expression	ISO	4	152,610,283	152,657,891	RGD:6480464	CTD
G	Amhr2	anti-Mullerian hormone receptor, type II		decreases expression	ISO	7	141,203,832	141,212,653	RGD:6480464	CTD
G	Apoe	apolipoprotein E		increases expression	ISO	1	79,003,634	79,006,387	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		multiple interactions	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		decreases expression	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		decreases expression	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		multiple interactions	EXP	11	24,457,855	24,693,851	RGD:6480464	CTD
G	Arid1a	AT rich interactive domain 1A (SWI-like)		decreases expression	ISO	5	151,355,617	151,398,647	RGD:6480464	CTD
G	Arrb1	arrestin, beta 1		multiple interactions	ISO	1	156,871,564	156,937,540	RGD:6480464	CTD
G	Atf3	activating transcription factor 3		increases expression	ISO	13	107,191,622	107,223,850	RGD:6480464	CTD
G	Atf6	activating transcription factor 6		multiple interactions	EXP	13	86,543,773	86,718,970	RGD:6480464	CTD
G	Avp	arginine vasopressin		decreases expression	ISO	3	118,205,007	118,206,985	RGD:6480464	CTD
G	Avp	arginine vasopressin		increases secretion	EXP	3	118,205,007	118,206,985	RGD:6480464	CTD
G	B4galt2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2		decreases expression	ISO	5	138,338,706	138,347,177	RGD:6480464	CTD
G	Bad	BCL2-associated agonist of cell death		decreases expression	ISO	1	209,617,373	209,626,292	RGD:6480464	CTD
G	Bad	BCL2-associated agonist of cell death		decreases phosphorylation	EXP	1	209,617,373	209,626,292	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		decreases expression	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases phosphorylation	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		decreases expression	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		affects localization	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases phosphorylation	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2a1	BCL2-related protein A1		decreases expression	ISO	8	94,045,109	94,053,777	RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		affects response to substance	ISO				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		multiple interactions	ISO				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases secretion	ISO				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		affects expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bglap	bone gamma-carboxyglutamate (gla) protein		decreases expression	ISO	2	180,482,313	180,483,290	RGD:6480464	CTD
G	Bglap	bone gamma-carboxyglutamate (gla) protein		increases expression	ISO	2	180,482,313	180,483,290	RGD:6480464	CTD
G	Bglap	bone gamma-carboxyglutamate (gla) protein		multiple interactions	ISO	2	180,482,313	180,483,290	RGD:6480464	CTD
G	Birc2	baculoviral IAP repeat-containing 2		increases expression	ISO	8	4,649,559	4,667,733	RGD:6480464	CTD
G	Birc2	baculoviral IAP repeat-containing 2		multiple interactions	ISO	8	4,649,559	4,667,733	RGD:6480464	CTD
G	Birc5	baculoviral IAP repeat-containing 5		multiple interactions	ISO				RGD:6480464	CTD
G	Birc5	baculoviral IAP repeat-containing 5		multiple interactions	ISO				RGD:6480464	CTD
G	Birc5	baculoviral IAP repeat-containing 5		increases expression	ISO				RGD:6480464	CTD
G	Birc5	baculoviral IAP repeat-containing 5		increases expression	ISO				RGD:6480464	CTD
G	Bmp4	bone morphogenetic protein 4		decreases expression	EXP	15	22,283,171	22,286,757	RGD:6480464	CTD
G	Braf	v-raf murine sarcoma viral oncogene homolog B1		decreases expression	ISO	4	67,117,759	67,243,058	RGD:6480464	CTD
G	Brca1	breast cancer 1, early onset		decreases expression	ISO	10	90,513,630	90,572,676	RGD:6480464	CTD
G	Btf3	basic transcription factor 3		decreases expression	ISO	2	28,900,451	28,907,561	RGD:6480464	CTD
G	Btg2	BTG family, member 2		increases expression	ISO	13	47,026,986	47,030,745	RGD:6480464	CTD
G	Btk	Bruton agammaglobulinemia tyrosine kinase		decreases expression	ISO	X	121,998,935	122,030,289	RGD:6480464	CTD
G	C5ar1	complement component 5a receptor 1		decreases expression	ISO				RGD:6480464	CTD
G	Cacna1c	calcium channel, voltage-dependent, L type, alpha 1C subunit		increases expression	ISO	4	154,895,691	155,517,389	RGD:6480464	CTD
G	Cacna1d	calcium channel, voltage-dependent, L type, alpha 1D subunit		increases expression	ISO	16	5,383,259	5,703,361	RGD:6480464	CTD
G	Cacna1f	calcium channel, voltage-dependent, L type, alpha 1F subunit		increases expression	ISO	X	26,908,850	26,937,165	RGD:6480464	CTD
G	Cacna2d1	calcium channel, voltage-dependent, alpha2/delta subunit 1		increases expression	ISO	4	15,139,881	15,566,740	RGD:6480464	CTD
G	Calb1	calbindin 1		multiple interactions	EXP	5	30,455,665	30,480,122	RGD:6480464	CTD
G	Calb1	calbindin 1		increases expression	EXP	5	30,455,665	30,480,122	RGD:6480464	CTD
G	Calcrl	calcitonin receptor-like		multiple interactions	EXP	3	67,553,022	67,646,877	RGD:6480464	CTD
G	Camk4	calcium/calmodulin-dependent protein kinase IV		decreases expression	ISO	18	25,404,123	25,625,785	RGD:6480464	CTD
G	Capn10	calpain 10		increases expression	ISO				RGD:6480464	CTD
G	Cartpt	CART prepropeptide		decreases expression	ISO	2	30,889,817	30,891,837	RGD:6480464	CTD
G	Casp1	caspase 1		multiple interactions	ISO	8	2,027,976	2,036,872	RGD:6480464	CTD
G	Casp12	caspase 12		multiple interactions	EXP	8	2,082,933	2,110,511	RGD:6480464	CTD
G	Casp2	caspase 2		affects expression	EXP	4	70,029,728	70,047,164	RGD:6480464	CTD
G	Casp3	caspase 3		decreases expression	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases expression	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		affects expression	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases expression	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		decreases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		decreases expression	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases expression	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases expression	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp8	caspase 8		affects expression	EXP	9	57,389,353	57,437,803	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		decreases activity	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		increases activity	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cbl	Cbl proto-oncogene, E3 ubiquitin protein ligase		increases expression	ISO	8	47,135,357	47,211,889	RGD:6480464	CTD
G	Ccdc88a	coiled coil domain containing 88A		increases expression	ISO	14	110,376,486	110,525,468	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		multiple interactions	EXP	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		decreases expression	EXP	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		decreases expression	EXP	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Ccl5	chemokine (C-C motif) ligand 5		increases expression	ISO	10	71,605,791	71,610,330	RGD:6480464	CTD
G	Ccna2	cyclin A2		increases expression	ISO	2	123,062,752	123,069,085	RGD:6480464	CTD
G	Ccnb1	cyclin B1		increases expression	ISO	2	31,574,600	31,581,784	RGD:6480464	CTD
G	Ccnd1	cyclin D1		multiple interactions	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		multiple interactions	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		multiple interactions	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		multiple interactions	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		multiple interactions	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		increases expression	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		increases expression	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		decreases expression	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		increases expression	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		increases activity	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		increases expression	EXP	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd2	cyclin D2		decreases expression	ISO	4	163,523,817	163,546,501	RGD:6480464	CTD
G	Ccne1	cyclin E1		increases expression	ISO	1	90,568,189	90,577,426	RGD:6480464	CTD
G	Ccne1	cyclin E1		multiple interactions	ISO	1	90,568,189	90,577,426	RGD:6480464	CTD
G	Ccr5	chemokine (C-C motif) receptor 5		increases expression	ISO	8	128,907,157	128,912,272	RGD:6480464	CTD
G	Ccr6	chemokine (C-C motif) receptor 6		decreases expression	ISO	1	47,115,472	47,139,825	RGD:6480464	CTD
G	Ccs	copper chaperone for superoxide dismutase		increases expression	ISO	1	207,429,928	207,450,996	RGD:6480464	CTD
G	Cd4	Cd4 molecule		decreases expression	ISO	4	160,988,512	161,014,038	RGD:6480464	CTD
G	Cd59	CD59 molecule, complement regulatory protein		increases expression	ISO	3	89,243,600	89,245,129	RGD:6480464	CTD
G	Cdc25a	cell division cycle 25A		multiple interactions	ISO	8	114,237,704	114,255,971	RGD:6480464	CTD
G	Cdc6	cell division cycle 6		multiple interactions	ISO	10	87,684,493	87,697,865	RGD:6480464	CTD
G	Cdh1	cadherin 1		multiple interactions	ISO	19	36,442,693	36,512,091	RGD:6480464	CTD
G	Cdh1	cadherin 1		decreases expression	ISO	19	36,442,693	36,512,091	RGD:6480464	CTD
G	Cdh1	cadherin 1		decreases expression	ISO	19	36,442,693	36,512,091	RGD:6480464	CTD
G	Cdk4	cyclin-dependent kinase 4		multiple interactions	ISO				RGD:6480464	CTD
G	Cdk4	cyclin-dependent kinase 4		multiple interactions	ISO				RGD:6480464	CTD
G	Cdk4	cyclin-dependent kinase 4		decreases expression	ISO				RGD:6480464	CTD
G	Cdk4	cyclin-dependent kinase 4		decreases expression	ISO				RGD:6480464	CTD
G	Cdk6	cyclin-dependent kinase 6		multiple interactions	ISO	4	27,362,656	27,618,006	RGD:6480464	CTD
G	Cdkn1a	cyclin-dependent kinase inhibitor 1A		multiple interactions	ISO	20	7,376,325	7,386,778	RGD:6480464	CTD
G	Cdkn1a	cyclin-dependent kinase inhibitor 1A		multiple interactions	ISO	20	7,376,325	7,386,778	RGD:6480464	CTD
G	Cdkn1a	cyclin-dependent kinase inhibitor 1A		increases expression	ISO	20	7,376,325	7,386,778	RGD:6480464	CTD
G	Cdkn1a	cyclin-dependent kinase inhibitor 1A		decreases expression	ISO	20	7,376,325	7,386,778	RGD:6480464	CTD
G	Cdkn1b	cyclin-dependent kinase inhibitor 1B		multiple interactions	ISO	4	171,841,705	171,846,506	RGD:6480464	CTD
G	Cdkn1b	cyclin-dependent kinase inhibitor 1B		decreases expression	ISO	4	171,841,705	171,846,506	RGD:6480464	CTD
G	Cdkn1b	cyclin-dependent kinase inhibitor 1B		multiple interactions	ISO	4	171,841,705	171,846,506	RGD:6480464	CTD
G	Ceacam1	carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)		increases expression	ISO	1	80,742,540	80,758,943	RGD:6480464	CTD
G	Cebpb	CCAAT/enhancer binding protein (C/EBP), beta		increases expression	ISO	3	158,826,021	158,827,848	RGD:6480464	CTD
G	Cetn2	centrin, EF-hand protein, 2		decreases expression	ISO	X	158,917,650	158,923,210	RGD:6480464	CTD
G	Chat	choline O-acetyltransferase		decreases activity	EXP	16	7,913,026	7,965,985	RGD:6480464	CTD
G	Chat	choline O-acetyltransferase		increases activity	EXP	16	7,913,026	7,965,985	RGD:6480464	CTD
G	Chrna2	cholinergic receptor, nicotinic, alpha 2 (neuronal)		affects response to substance	ISO	15	45,570,809	45,587,091	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		decreases expression	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	EXP	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		affects response to substance	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		increases expression	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	EXP	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		increases activity	EXP	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		increases expression	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		affects response to substance	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		affects response to substance	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		affects response to substance	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		increases response to substance	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		decreases expression	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		increases expression	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		affects binding	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		affects binding	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		decreases expression	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna5	cholinergic receptor, nicotinic, alpha 5 (neuronal)		multiple interactions	ISO	8	58,538,002	58,566,388	RGD:6480464	CTD
G	Chrna5	cholinergic receptor, nicotinic, alpha 5 (neuronal)		increases response to substance	ISO	8	58,538,002	58,566,388	RGD:6480464	CTD
G	Chrna5	cholinergic receptor, nicotinic, alpha 5 (neuronal)		decreases expression	ISO	8	58,538,002	58,566,388	RGD:6480464	CTD
G	Chrna5	cholinergic receptor, nicotinic, alpha 5 (neuronal)		increases expression	ISO	8	58,538,002	58,566,388	RGD:6480464	CTD
G	Chrna5	cholinergic receptor, nicotinic, alpha 5 (neuronal)		affects response to substance	ISO	8	58,538,002	58,566,388	RGD:6480464	CTD
G	Chrna6	cholinergic receptor, nicotinic, alpha 6 (neuronal)		decreases expression	ISO	16	69,012,201	69,018,901	RGD:6480464	CTD
G	Chrna6	cholinergic receptor, nicotinic, alpha 6 (neuronal)		affects response to substance	ISO	16	69,012,201	69,018,901	RGD:6480464	CTD
G	Chrna6	cholinergic receptor, nicotinic, alpha 6 (neuronal)		multiple interactions	ISO	16	69,012,201	69,018,901	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases expression	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases expression	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		decreases expression	EXP	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		decreases expression	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases expression	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases expression	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		affects response to substance	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		affects response to substance	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases response to substance	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		increases expression	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		affects response to substance	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		affects binding	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		decreases expression	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		affects response to substance	ISO	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		multiple interactions	EXP	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		increases activity	EXP	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Ckmt2	creatine kinase, mitochondrial 2, sarcomeric		decreases expression	ISO	2	22,084,948	22,106,014	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		multiple interactions	ISO	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		affects response to substance	ISO	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cox7c	cytochrome c oxidase, subunit VIIc		multiple interactions	ISO	2	15,254,040	15,256,065	RGD:6480464	CTD
G	Creb1	cAMP responsive element binding protein 1		decreases expression	ISO	9	63,170,785	63,234,727	RGD:6480464	CTD
G	Csf2	colony stimulating factor 2 (granulocyte-macrophage)		multiple interactions	ISO	10	39,665,850	39,667,831	RGD:6480464	CTD
G	Cxcl1	chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)		increases expression	ISO	14	18,690,339	18,692,118	RGD:6480464	CTD
G	Cxcr2	chemokine (C-X-C motif) receptor 2		decreases expression	ISO	9	73,470,943	73,477,315	RGD:6480464	CTD
G	Cxcr2	chemokine (C-X-C motif) receptor 2		increases expression	ISO	9	73,470,943	73,477,315	RGD:6480464	CTD
G	Cxcr3	chemokine (C-X-C motif) receptor 3		increases expression	ISO	X	89,794,276	89,796,927	RGD:6480464	CTD
G	Cxcr4	chemokine (C-X-C motif) receptor 4		multiple interactions	ISO	13	41,308,286	41,312,190	RGD:6480464	CTD
G	Cxcr4	chemokine (C-X-C motif) receptor 4		increases expression	ISO	13	41,308,286	41,312,190	RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		decreases secretion	ISO	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		multiple interactions	ISO	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		affects localization	EXP	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		increases secretion	EXP	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		multiple interactions	EXP	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		increases expression	ISO	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		decreases activity	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		increases expression	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp26a1	cytochrome P450, family 26, subfamily a, polypeptide 1		decreases expression	ISO	1	241,945,472	241,949,220	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		increases expression	EXP	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		decreases metabolic processing	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		decreases oxidation	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		affects metabolic processing	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		multiple interactions	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		affects oxidation	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		increases metabolic processing	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		decreases metabolic processing	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		affects metabolic processing	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		multiple interactions	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		increases metabolic processing	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		multiple interactions	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		increases oxidation	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		multiple interactions	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		increases hydroxylation	EXP	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2b1	cytochrome P450, family 2, subfamily b, polypeptide 1		increases metabolic processing	EXP	1	81,266,828	81,290,471	RGD:6480464	CTD
G	Cyp2b1	cytochrome P450, family 2, subfamily b, polypeptide 1		increases expression	EXP	1	81,266,828	81,290,471	RGD:6480464	CTD
G	Cyp2b1	cytochrome P450, family 2, subfamily b, polypeptide 1		increases expression	EXP	1	81,266,828	81,290,471	RGD:6480464	CTD
G	Cyp2b1	cytochrome P450, family 2, subfamily b, polypeptide 1		multiple interactions	EXP	1	81,266,828	81,290,471	RGD:6480464	CTD
G	Cyp2b2	cytochrome P450, family 2, subfamily b, polypeptide 2		multiple interactions	ISO	1	81,345,425	81,359,415	RGD:6480464	CTD
G	Cyp2b2	cytochrome P450, family 2, subfamily b, polypeptide 2		increases metabolic processing	ISO	1	81,345,425	81,359,415	RGD:6480464	CTD
G	Cyp2e1	cytochrome P450, family 2, subfamily e, polypeptide 1		increases expression	EXP	1	200,918,521	200,928,919	RGD:6480464	CTD
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		multiple interactions	ISO	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Cyr61	cysteine-rich, angiogenic inducer, 61		increases expression	ISO	2	243,824,303	243,827,262	RGD:6480464	CTD
G	Dbh	dopamine beta-hydroxylase (dopamine beta-monooxygenase)		multiple interactions	ISO	3	6,052,706	6,069,826	RGD:6480464	CTD
G	Dbh	dopamine beta-hydroxylase (dopamine beta-monooxygenase)		increases expression	ISO	3	6,052,706	6,069,826	RGD:6480464	CTD
G	Ddit3	DNA-damage inducible transcript 3		multiple interactions	ISO	7	67,247,749	67,252,571	RGD:6480464	CTD
G	Ddit4	DNA-damage-inducible transcript 4		increases expression	ISO	20	27,252,273	27,254,371	RGD:6480464	CTD
G	Dedd	death effector domain-containing		decreases expression	ISO	13	87,238,315	87,241,703	RGD:6480464	CTD
G	Dffb	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)		decreases expression	ISO	5	170,750,718	170,762,034	RGD:6480464	CTD
G	Dhx36	DEAH (Asp-Glu-Ala-His) box polypeptide 36		increases expression	ISO	2	152,122,767	152,161,219	RGD:6480464	CTD
G	Dnase2	deoxyribonuclease II, lysosomal		decreases expression	ISO	19	24,900,949	24,903,617	RGD:6480464	CTD
G	Dnm1l	dynamin 1-like		increases expression	ISO	11	86,617,236	86,665,861	RGD:6480464	CTD
G	Drd1	dopamine receptor D1		multiple interactions	EXP	17	16,655,926	16,658,161	RGD:6480464	CTD
G	Drd2	dopamine receptor D2		multiple interactions	EXP	8	52,641,160	52,707,749	RGD:6480464	CTD
G	Dusp1	dual specificity phosphatase 1		increases expression	ISO	10	16,942,913	16,945,696	RGD:6480464	CTD
G	Dusp11	dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)		decreases expression	ISO	4	120,094,173	120,108,207	RGD:6480464	CTD
G	Dusp6	dual specificity phosphatase 6		increases expression	ISO	7	36,893,264	36,897,494	RGD:6480464	CTD
G	E2f1	E2F transcription factor 1		multiple interactions	ISO	3	145,032,489	145,043,729	RGD:6480464	CTD
G	E2f1	E2F transcription factor 1		multiple interactions	ISO	3	145,032,489	145,043,729	RGD:6480464	CTD
G	E2f1	E2F transcription factor 1		multiple interactions	ISO	3	145,032,489	145,043,729	RGD:6480464	CTD
G	E2f1	E2F transcription factor 1		increases expression	ISO	3	145,032,489	145,043,729	RGD:6480464	CTD
G	E2f3	E2F transcription factor 3		multiple interactions	ISO	17	41,079,346	41,145,568	RGD:6480464	CTD
G	E2f4	E2F transcription factor 4, p107/p130-binding		multiple interactions	ISO	19	35,112,273	35,118,888	RGD:6480464	CTD
G	E2f5	E2F transcription factor 5		multiple interactions	ISO	2	88,346,236	88,361,733	RGD:6480464	CTD
G	Ednra	endothelin receptor type A		decreases expression	ISO	19	32,042,366	32,108,153	RGD:6480464	CTD
G	Eef2	eukaryotic translation elongation factor 2		multiple interactions	ISO	7	10,017,061	10,022,331	RGD:6480464	CTD
G	Eef2	eukaryotic translation elongation factor 2		increases expression	ISO	7	10,017,061	10,022,331	RGD:6480464	CTD
G	Egfr	epidermal growth factor receptor		multiple interactions	ISO	14	97,617,358	97,788,211	RGD:6480464	CTD
G	Egfr	epidermal growth factor receptor		increases phosphorylation	ISO	14	97,617,358	97,788,211	RGD:6480464	CTD
G	Egr1	early growth response 1		increases expression	ISO	18	27,343,919	27,346,117	RGD:6480464	CTD
G	Egr1	early growth response 1		decreases expression	ISO	18	27,343,919	27,346,117	RGD:6480464	CTD
G	Egr2	early growth response 2		increases expression	ISO	20	21,883,885	21,888,177	RGD:6480464	CTD
G	Eif4ebp1	eukaryotic translation initiation factor 4E binding protein 1		multiple interactions	ISO	16	69,110,522	69,123,895	RGD:6480464	CTD
G	Emc3	ER membrane protein complex subunit 3		decreases expression	ISO	4	149,405,742	149,422,064	RGD:6480464	CTD
G	Emcn	endomucin		increases expression	ISO	2	234,892,271	234,972,226	RGD:6480464	CTD
G	Enc1	ectodermal-neural cortex 1		decreases expression	ISO	2	27,720,805	27,733,168	RGD:6480464	CTD
G	Eng	endoglin		decreases expression	ISO				RGD:6480464	CTD
G	Epha3	Eph receptor A3		decreases expression	ISO	11	696,185	1,033,287	RGD:6480464	CTD
G	Ephb3	Eph receptor B3		decreases expression	ISO	11	82,027,632	82,046,332	RGD:6480464	CTD
G	Epo	erythropoietin		increases expression	ISO	12	19,551,768	19,555,208	RGD:6480464	CTD
G	Errfi1	ERBB receptor feedback inhibitor 1		increases expression	ISO	5	168,012,683	168,025,963	RGD:6480464	CTD
G	Etfb	electron-transfer-flavoprotein, beta polypeptide		decreases expression	ISO	1	93,820,124	93,834,288	RGD:6480464	CTD
G	Ezr	ezrin		increases expression	ISO	1	41,178,195	41,221,735	RGD:6480464	CTD
G	F2	coagulation factor II		increases expression	ISO	3	76,005,318	76,018,603	RGD:6480464	CTD
G	F3	coagulation factor III (thromboplastin, tissue factor)		increases expression	ISO	2	218,371,050	218,382,645	RGD:6480464	CTD
G	Fam120a	family with sequence similarity 120A		decreases expression	ISO	17	21,673,373	21,764,457	RGD:6480464	CTD
G	Fas	Fas cell surface death receptor		increases expression	ISO	1	238,259,443	238,274,745	RGD:6480464	CTD
G	Fas	Fas cell surface death receptor		increases expression	EXP	1	238,259,443	238,274,745	RGD:6480464	CTD
G	Faslg	Fas ligand (TNF superfamily, member 6)		increases expression	ISO	13	77,472,950	77,480,210	RGD:6480464	CTD
G	Faslg	Fas ligand (TNF superfamily, member 6)		increases expression	ISO	13	77,472,950	77,480,210	RGD:6480464	CTD
G	Faslg	Fas ligand (TNF superfamily, member 6)		affects expression	EXP	13	77,472,950	77,480,210	RGD:6480464	CTD
G	Faslg	Fas ligand (TNF superfamily, member 6)		increases expression	EXP	13	77,472,950	77,480,210	RGD:6480464	CTD
G	Fasn	fatty acid synthase		multiple interactions	ISO				RGD:6480464	CTD
G	Fasn	fatty acid synthase		decreases activity	ISO				RGD:6480464	CTD
G	Fbn1	fibrillin 1		increases expression	ISO	3	112,608,480	112,804,118	RGD:6480464	CTD
G	Fbxw5	F-box and WD repeat domain containing 5		decreases expression	ISO	3	3,673,918	3,677,876	RGD:6480464	CTD
G	Fgf2	fibroblast growth factor 2		increases secretion	ISO	2	123,893,314	123,947,136	RGD:6480464	CTD
G	Fgf2	fibroblast growth factor 2		multiple interactions	EXP	2	123,893,314	123,947,136	RGD:6480464	CTD
G	Fgf2	fibroblast growth factor 2		increases expression	EXP	2	123,893,314	123,947,136	RGD:6480464	CTD
G	Fgf2	fibroblast growth factor 2		increases expression	EXP	2	123,893,314	123,947,136	RGD:6480464	CTD
G	Fgf2	fibroblast growth factor 2		decreases expression	EXP	2	123,893,314	123,947,136	RGD:6480464	CTD
G	Flt3	fms-related tyrosine kinase 3		decreases expression	ISO	12	8,193,629	8,268,682	RGD:6480464	CTD
G	Fmo3	flavin containing monooxygenase 3		increases metabolic processing	ISO	13	78,659,513	78,678,524	RGD:6480464	CTD
G	Fn1	fibronectin 1		decreases expression	ISO	9	70,702,181	70,771,155	RGD:6480464	CTD
G	Fn1	fibronectin 1		increases expression	ISO	9	70,702,181	70,771,155	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	ISO	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	ISO	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fosb	FBJ osteosarcoma oncogene B		increases expression	ISO	1	78,668,497	78,673,330	RGD:6480464	CTD
G	Fosb	FBJ osteosarcoma oncogene B		increases expression	EXP	1	78,668,497	78,673,330	RGD:6480464	CTD
G	Foxo1	forkhead box O1		multiple interactions	ISO	2	141,127,345	141,203,446	RGD:6480464	CTD
G	Fshb	follicle stimulating hormone, beta polypeptide		decreases expression	EXP	3	92,569,344	92,571,254	RGD:6480464	CTD
G	Fxyd1	FXYD domain-containing ion transport regulator 1		increases expression	ISO	1	86,095,551	86,098,079	RGD:6480464	CTD
G	G6pd	glucose-6-phosphate dehydrogenase		decreases activity	EXP	X	160,186,450	160,192,316	RGD:6480464	CTD
G	Gad1	glutamate decarboxylase 1		increases expression	EXP	3	52,789,370	52,830,038	RGD:6480464	CTD
G	Galk2	galactokinase 2		increases expression	ISO	3	113,173,734	113,418,061	RGD:6480464	CTD
G	Gata2	GATA binding protein 2		multiple interactions	ISO	4	122,279,753	122,288,528	RGD:6480464	CTD
G	Gata2	GATA binding protein 2		increases expression	ISO	4	122,279,753	122,288,528	RGD:6480464	CTD
G	Gcnt2	glucosaminyl (N-acetyl) transferase 2, I-branching enzyme		increases expression	ISO	17	29,767,383	29,808,950	RGD:6480464	CTD
G	Gdf1	growth differentiation factor 1		increases expression	ISO	16	19,580,807	19,596,415	RGD:6480464	CTD
G	Gem	GTP binding protein overexpressed in skeletal muscle		increases expression	ISO	5	25,809,543	26,008,249	RGD:6480464	CTD
G	Gfap	glial fibrillary acidic protein		increases expression	ISO	10	92,059,881	92,068,555	RGD:6480464	CTD
G	Gprasp1	G protein-coupled receptor associated sorting protein 1		increases expression	ISO				RGD:6480464	CTD
G	Gpx1	glutathione peroxidase 1		increases expression	EXP				RGD:6480464	CTD
G	Grik2	glutamate receptor, ionotropic, kainate 2		increases expression	ISO	20	53,231,473	53,713,131	RGD:6480464	CTD
G	Gsk3a	glycogen synthase kinase 3 alpha		multiple interactions	ISO	1	80,505,517	80,514,139	RGD:6480464	CTD
G	Gsk3b	glycogen synthase kinase 3 beta		multiple interactions	ISO	11	64,284,731	64,428,698	RGD:6480464	CTD
G	Gsr	glutathione reductase		decreases activity	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsta4	glutathione S-transferase alpha 4		decreases expression	EXP	8	83,165,139	83,183,055	RGD:6480464	CTD
G	Gsta4	glutathione S-transferase alpha 4		increases activity	EXP	8	83,165,139	83,183,055	RGD:6480464	CTD
G	Gsta4	glutathione S-transferase alpha 4		increases expression	EXP	8	83,165,139	83,183,055	RGD:6480464	CTD
G	Gstk1	glutathione S-transferase kappa 1		decreases expression	ISO	4	69,999,767	70,004,086	RGD:6480464	CTD
G	H2afv	H2A histone family, member V		decreases expression	ISO				RGD:6480464	CTD
G	Havcr1	hepatitis A virus cellular receptor 1		increases expression	ISO	10	31,834,519	31,858,019	RGD:6480464	CTD
G	Hint1	histidine triad nucleotide binding protein 1		increases expression	ISO	10	40,271,895	40,275,640	RGD:6480464	CTD
G	Hint1	histidine triad nucleotide binding protein 1		multiple interactions	ISO	10	40,271,895	40,275,640	RGD:6480464	CTD
G	Hint1	histidine triad nucleotide binding protein 1		increases expression	ISO	10	40,271,895	40,275,640	RGD:6480464	CTD
G	Hltf	helicase-like transcription factor		decreases expression	ISO	2	105,202,487	105,262,107	RGD:6480464	CTD
G	Hnrnpa3	heterogeneous nuclear ribonucleoprotein A3		increases expression	ISO	3	68,872,863	68,875,337	RGD:6480464	CTD
G	Hnrnph2	heterogeneous nuclear ribonucleoprotein H2 (H')		increases expression	ISO	X	122,056,647	122,061,844	RGD:6480464	CTD
G	Hnrpll	heterogeneous nuclear ribonucleoprotein L-like		increases expression	ISO	6	2,909,705	2,940,020	RGD:6480464	CTD
G	Hras	Harvey rat sarcoma virus oncogene		increases activity	EXP	1	201,385,705	201,388,987	RGD:6480464	CTD
G	Hsd17b1	hydroxysteroid (17-beta) dehydrogenase 1		decreases expression	EXP	10	90,094,249	90,096,451	RGD:6480464	CTD
G	Hsd17b1	hydroxysteroid (17-beta) dehydrogenase 1		multiple interactions	EXP	10	90,094,249	90,096,451	RGD:6480464	CTD
G	Hsp90aa1	heat shock protein 90, alpha (cytosolic), class A member 1		increases expression	ISO	6	135,413,616	135,419,147	RGD:6480464	CTD
G	Hspa5	heat shock protein 5		multiple interactions	EXP	3	13,783,825	13,788,022	RGD:6480464	CTD
G	Hspe1	heat shock protein 1 (chaperonin 10)		multiple interactions	ISO	9	53,895,333	53,898,421	RGD:6480464	CTD
G	Htr1a	5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled		decreases expression	ISO	2	36,434,518	36,435,786	RGD:6480464	CTD
G	Icam1	intercellular adhesion molecule 1		increases expression	EXP	8	20,040,177	20,051,939	RGD:6480464	CTD
G	Id1	inhibitor of DNA binding 1		decreases expression	ISO	3	143,086,162	143,087,289	RGD:6480464	CTD
G	Id3	inhibitor of DNA binding 3		decreases expression	ISO	5	154,934,138	154,935,707	RGD:6480464	CTD
G	Idi1	isopentenyl-diphosphate delta isomerase 1		decreases expression	ISO	17	72,557,196	72,563,149	RGD:6480464	CTD
G	Ifnar1	interferon (alpha, beta and omega) receptor 1		decreases expression	ISO	11	31,454,789	31,478,449	RGD:6480464	CTD
G	Igf1	insulin-like growth factor 1		decreases expression	EXP	7	24,531,669	24,605,742	RGD:6480464	CTD
G	Igf1	insulin-like growth factor 1		multiple interactions	EXP	7	24,531,669	24,605,742	RGD:6480464	CTD
G	Igf1r	insulin-like growth factor 1 receptor		increases expression	EXP	1	122,704,976	122,990,007	RGD:6480464	CTD
G	Igf1r	insulin-like growth factor 1 receptor		decreases expression	EXP	1	122,704,976	122,990,007	RGD:6480464	CTD
G	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2		increases expression	ISO	11	81,115,320	81,216,170	RGD:6480464	CTD
G	Il10	interleukin 10		decreases expression	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il1a	interleukin 1 alpha		multiple interactions	ISO	3	116,913,612	116,924,114	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases expression	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		decreases expression	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases expression	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il2	interleukin 2		decreases response to substance	ISO	2	123,655,005	123,659,709	RGD:6480464	CTD
G	Il3ra	interleukin 3 receptor, alpha		decreases expression	ISO	12	16,825,702	16,830,035	RGD:6480464	CTD
G	Il6	interleukin 6		increases expression	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il7	interleukin 7		multiple interactions	ISO	2	96,356,083	96,399,796	RGD:6480464	CTD
G	Il9	interleukin 9		decreases expression	ISO	17	14,068,757	14,071,880	RGD:6480464	CTD
G	Inppl1	inositol polyphosphate phosphatase-like 1		decreases expression	ISO	1	159,278,131	159,292,740	RGD:6480464	CTD
G	Ins2	insulin 2		increases expression	EXP	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Insr	insulin receptor		decreases expression	EXP	12	2,934,967	3,087,691	RGD:6480464	CTD
G	Irf8	interferon regulatory factor 8		decreases expression	ISO	19	51,100,088	51,116,730	RGD:6480464	CTD
G	Irgm2	immunity-related GTPase family M member 2		decreases expression	ISO	10	43,844,486	43,854,570	RGD:6480464	CTD
G	Itgal	integrin, alpha L		decreases expression	ISO	1	186,561,795	186,598,908	RGD:6480464	CTD
G	Itgav	integrin, alpha V		increases expression	ISO	3	66,953,403	67,029,774	RGD:6480464	CTD
G	Itgb1	integrin, beta 1		decreases expression	ISO	19	58,600,095	58,647,531	RGD:6480464	CTD
G	Itgb5	integrin, beta 5		increases expression	EXP				RGD:6480464	CTD
G	Ivl	involucrin		decreases expression	ISO	2	185,556,271	185,558,310	RGD:6480464	CTD
G	Jagn1	jagunal homolog 1 (Drosophila)		decreases expression	ISO				RGD:6480464	CTD
G	Jun	jun proto-oncogene		multiple interactions	ISO	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Jun	jun proto-oncogene		increases phosphorylation	ISO	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Jun	jun proto-oncogene		multiple interactions	EXP	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Junb	jun B proto-oncogene		decreases expression	ISO	19	24,831,536	24,833,320	RGD:6480464	CTD
G	Junb	jun B proto-oncogene		increases expression	ISO	19	24,831,536	24,833,320	RGD:6480464	CTD
G	Junb	jun B proto-oncogene		increases expression	ISO	19	24,831,536	24,833,320	RGD:6480464	CTD
G	Kcnh2	potassium voltage-gated channel, subfamily H (eag-related), member 2		increases expression	ISO	4	6,192,644	6,224,285	RGD:6480464	CTD
G	Kif3b	kinesin family member 3B		multiple interactions	ISO	3	143,642,175	143,681,902	RGD:6480464	CTD
G	Klf10	Kruppel-like factor 10		decreases expression	ISO	7	73,821,190	73,826,866	RGD:6480464	CTD
G	Klf10	Kruppel-like factor 10		increases expression	ISO	7	73,821,190	73,826,866	RGD:6480464	CTD
G	Klf11	Kruppel-like factor 11		decreases expression	ISO	6	42,296,221	42,307,925	RGD:6480464	CTD
G	Klf4	Kruppel-like factor 4 (gut)		increases expression	ISO	5	73,446,928	73,451,286	RGD:6480464	CTD
G	Kng1	kininogen 1		multiple interactions	EXP	11	80,109,499	80,131,887	RGD:6480464	CTD
G	Kng1	kininogen 1		decreases activity	EXP	11	80,109,499	80,131,887	RGD:6480464	CTD
G	Lcp1	lymphocyte cytosolic protein 1		affects response to substance	ISO	15	56,034,457	56,091,880	RGD:6480464	CTD
G	Lhb	luteinizing hormone beta		decreases expression	EXP	1	95,892,999	95,893,988	RGD:6480464	CTD
G	LOC100360260	chromobox homolog 3-like		increases expression	ISO	16	32,507,709	32,508,260	RGD:6480464	CTD
G	Lrrfip1	leucine rich repeat (in FLII) interacting protein 1		increases expression	ISO	9	90,278,891	90,346,980	RGD:6480464	CTD
G	Ltb	lymphotoxin beta (TNF superfamily, member 3)		decreases expression	ISO	20	3,666,524	3,668,369	RGD:6480464	CTD
G	Lyl1	lymphoblastic leukemia derived sequence 1		decreases expression	ISO	19	25,115,234	25,118,100	RGD:6480464	CTD
G	Lysmd3	LysM, putative peptidoglycan-binding, domain containing 3		affects response to substance	ISO	2	9,751,947	9,758,104	RGD:6480464	CTD
G	Madd	MAP-kinase activating death domain		decreases expression	ISO	3	75,498,321	75,541,073	RGD:6480464	CTD
G	Map2k6	mitogen-activated protein kinase kinase 6		increases expression	EXP	10	99,859,684	99,974,446	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		increases expression	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		increases activity	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		increases phosphorylation	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		decreases expression	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		increases phosphorylation	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk11	mitogen-activated protein kinase 11		decreases expression	ISO	7	127,444,055	127,449,990	RGD:6480464	CTD
G	Mapk13	mitogen activated protein kinase 13		decreases expression	ISO	20	7,055,313	7,064,405	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		decreases expression	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		increases phosphorylation	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		decreases expression	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk8	mitogen-activated protein kinase 8		multiple interactions	ISO	16	8,925,133	9,004,897	RGD:6480464	CTD
G	Mapk8	mitogen-activated protein kinase 8		multiple interactions	ISO	16	8,925,133	9,004,897	RGD:6480464	CTD
G	Mapk8	mitogen-activated protein kinase 8		increases phosphorylation	ISO	16	8,925,133	9,004,897	RGD:6480464	CTD
G	Mapk8	mitogen-activated protein kinase 8		increases phosphorylation	ISO	16	8,925,133	9,004,897	RGD:6480464	CTD
G	Mapk8	mitogen-activated protein kinase 8		increases activity	EXP	16	8,925,133	9,004,897	RGD:6480464	CTD
G	Mapk8	mitogen-activated protein kinase 8		multiple interactions	EXP	16	8,925,133	9,004,897	RGD:6480464	CTD
G	Mapk8	mitogen-activated protein kinase 8		increases expression	EXP	16	8,925,133	9,004,897	RGD:6480464	CTD
G	Mbp	myelin basic protein		increases phosphorylation	EXP	18	78,943,608	79,057,329	RGD:6480464	CTD
G	Mcl1	myeloid cell leukemia sequence 1		increases phosphorylation	ISO				RGD:6480464	CTD
G	Mcl1	myeloid cell leukemia sequence 1		multiple interactions	ISO				RGD:6480464	CTD
G	Mef2c	myocyte enhancer factor 2C		affects expression	EXP	2	12,331,078	12,346,520	RGD:6480464	CTD
G	Mettl3	methyltransferase-like 3		increases expression	ISO	15	27,743,959	27,754,787	RGD:6480464	CTD
G	Mgp	matrix Gla protein		multiple interactions	EXP	4	173,910,595	173,913,917	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		increases expression	ISO	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp7	matrix metallopeptidase 7		multiple interactions	ISO	8	4,526,018	4,533,730	RGD:6480464	CTD
G	Mmp7	matrix metallopeptidase 7		increases expression	ISO	8	4,526,018	4,533,730	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		increases expression	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		multiple interactions	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		increases expression	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mpo	myeloperoxidase		decreases activity	EXP	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Mrpl41	mitochondrial ribosomal protein L41		decreases expression	ISO	3	5,120,299	5,121,217	RGD:6480464	CTD
G	Mrpl54	mitochondrial ribosomal protein L54		increases expression	ISO	7	9,936,603	9,939,123	RGD:6480464	CTD
G	Mst1	Macrophage stimulating 1 (hepatocyte growth factor-like)		decreases expression	ISO	8	113,348,203	113,352,773	RGD:6480464	CTD
G	Msx1	msh homeobox 1		increases expression	EXP	14	78,257,345	78,261,144	RGD:6480464	CTD
G	Myc	myelocytomatosis oncogene		increases activity	ISO	7	98,953,142	98,958,060	RGD:6480464	CTD
G	Myc	myelocytomatosis oncogene		multiple interactions	ISO	7	98,953,142	98,958,060	RGD:6480464	CTD
G	Myc	myelocytomatosis oncogene		decreases expression	ISO	7	98,953,142	98,958,060	RGD:6480464	CTD
G	Myo5b	myosin Vb		decreases expression	ISO	18	71,381,068	71,580,824	RGD:6480464	CTD
G	Myo9a	myosin IXA		increases expression	ISO	8	63,578,001	63,783,813	RGD:6480464	CTD
G	Nedd9	neural precursor cell expressed, developmentally down-regulated 9		increases expression	ISO	17	29,304,750	29,354,613	RGD:6480464	CTD
G	Nefm	neurofilament, medium polypeptide		increases expression	ISO	15	47,698,371	47,703,350	RGD:6480464	CTD
G	Nfatc2	nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2		multiple interactions	ISO	3	159,656,032	159,773,643	RGD:6480464	CTD
G	Nfkb1	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1		increases activity	ISO	2	233,091,013	233,187,501	RGD:6480464	CTD
G	Nfkb1	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1		increases expression	ISO	2	233,091,013	233,187,501	RGD:6480464	CTD
G	Nfkb1	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1		multiple interactions	ISO	2	233,091,013	233,187,501	RGD:6480464	CTD
G	Nfkb1	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1		decreases expression	ISO	2	233,091,013	233,187,501	RGD:6480464	CTD
G	Nfkbia	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		increases expression	ISO	6	75,729,302	75,732,475	RGD:6480464	CTD
G	Nfkbia	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		increases degradation	EXP	6	75,729,302	75,732,475	RGD:6480464	CTD
G	Nfkbie	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon		decreases expression	ISO	9	11,044,112	11,050,948	RGD:6480464	CTD
G	Nfyb	nuclear transcription factor-Y beta		decreases expression	ISO	7	23,190,295	23,205,611	RGD:6480464	CTD
G	Nme3	NME/NM23 nucleoside diphosphate kinase 3		decreases expression	ISO	10	14,145,488	14,146,444	RGD:6480464	CTD
G	Nme6	NME/NM23 nucleoside diphosphate kinase 6		decreases expression	ISO	8	114,205,773	114,212,486	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		decreases expression	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases expression	ISO	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Notch4	notch 4		decreases expression	EXP	20	4,263,205	4,287,312	RGD:6480464	CTD
G	Notch4	notch 4		multiple interactions	EXP	20	4,263,205	4,287,312	RGD:6480464	CTD
G	Nox4	NADPH oxidase 4		increases expression	ISO	1	143,415,816	143,603,554	RGD:6480464	CTD
G	Nr4a1	nuclear receptor subfamily 4, group A, member 1		increases expression	ISO	7	140,012,807	140,020,590	RGD:6480464	CTD
G	Ntrk2	neurotrophic tyrosine kinase, receptor, type 2		multiple interactions	ISO	17	11,494,463	11,811,654	RGD:6480464	CTD
G	Ntrk2	neurotrophic tyrosine kinase, receptor, type 2		increases expression	ISO	17	11,494,463	11,811,654	RGD:6480464	CTD
G	Nudt4	nudix (nucleoside diphosphate linked moiety X)-type motif 4		increases expression	ISO	7	32,753,728	32,769,953	RGD:6480464	CTD
G	Oprd1	opioid receptor, delta 1		multiple interactions	ISO	5	150,979,252	151,014,066	RGD:6480464	CTD
G	Oprk1	opioid receptor, kappa 1		decreases expression	ISO	5	14,040,848	14,055,273	RGD:6480464	CTD
G	Oprl1	opiate receptor-like 1		affects response to substance	ISO	3	170,869,862	170,873,417	RGD:6480464	CTD
G	Oprm1	opioid receptor, mu 1		multiple interactions	ISO	1	37,535,416	37,779,392	RGD:6480464	CTD
G	Parp1	poly (ADP-ribose) polymerase 1		multiple interactions	ISO	13	96,309,670	96,341,486	RGD:6480464	CTD
G	Pax3	paired box 3		decreases expression	EXP	9	77,477,813	77,576,632	RGD:6480464	CTD
G	Pcf11	PCF11, cleavage and polyadenylation factor subunit, homolog (S. cerevisiae)		increases expression	ISO	1	149,474,824	149,501,334	RGD:6480464	CTD
G	Pcna	proliferating cell nuclear antigen		increases expression	ISO	3	120,008,715	120,012,589	RGD:6480464	CTD
G	Pdgfa	platelet-derived growth factor alpha polypeptide		affects expression	EXP	12	16,151,045	16,172,412	RGD:6480464	CTD
G	Pdgfb	platelet-derived growth factor beta polypeptide		increases expression	ISO	7	118,244,385	118,262,021	RGD:6480464	CTD
G	Pdgfrb	platelet derived growth factor receptor, beta polypeptide		multiple interactions	EXP	18	57,014,475	57,053,581	RGD:6480464	CTD
G	Penk	proenkephalin		affects response to substance	ISO	5	17,509,323	17,514,265	RGD:6480464	CTD
G	Per1	period circadian clock 1		increases expression	ISO	10	55,859,851	55,868,747	RGD:6480464	CTD
G	Pes1	pescadillo ribosomal biogenesis factor 1		decreases expression	ISO	14	84,616,451	84,632,831	RGD:6480464	CTD
G	Phtf1	putative homeodomain transcription factor 1		decreases expression	ISO	2	199,202,647	199,241,476	RGD:6480464	CTD
G	Pick1	protein interacting with PRKCA 1		decreases expression	ISO	7	117,213,299	117,232,651	RGD:6480464	CTD
G	Pigf	phosphatidylinositol glycan anchor biosynthesis, class F		increases expression	ISO	6	10,446,734	10,474,805	RGD:6480464	CTD
G	Pla2g12a	phospholipase A2, group XIIA		decreases expression	ISO	2	227,331,049	227,348,091	RGD:6480464	CTD
G	Plat	plasminogen activator, tissue		increases expression	ISO	16	73,711,323	73,736,328	RGD:6480464	CTD
G	Plau	plasminogen activator, urokinase		multiple interactions	ISO	15	3,680,072	3,686,232	RGD:6480464	CTD
G	Plau	plasminogen activator, urokinase		increases expression	ISO	15	3,680,072	3,686,232	RGD:6480464	CTD
G	Plaur	plasminogen activator, urokinase receptor		multiple interactions	ISO	1	79,708,646	79,712,881	RGD:6480464	CTD
G	Plaur	plasminogen activator, urokinase receptor		increases expression	ISO	1	79,708,646	79,712,881	RGD:6480464	CTD
G	Plcg1	phospholipase C, gamma 1		multiple interactions	EXP	3	151,522,949	151,553,998	RGD:6480464	CTD
G	Pld2	phospholipase D2		increases expression	ISO	10	57,388,474	57,439,063	RGD:6480464	CTD
G	Plekhg1	pleckstrin homology domain containing, family G (with RhoGef domain) member 1		affects response to substance	ISO	1	34,591,855	34,677,812	RGD:6480464	CTD
G	Plk2	polo-like kinase 2		increases expression	ISO	2	41,800,745	41,806,503	RGD:6480464	CTD
G	Plod3	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3		decreases expression	ISO	12	20,856,527	20,867,088	RGD:6480464	CTD
G	Pnmt	phenylethanolamine-N-methyltransferase		increases expression	ISO				RGD:6480464	CTD
G	Pnoc	prepronociceptin		affects response to substance	ISO	15	44,822,635	44,835,637	RGD:6480464	CTD
G	Pomc	proopiomelanocortin		multiple interactions	ISO	6	26,931,969	26,937,789	RGD:6480464	CTD
G	Pomc	proopiomelanocortin		affects response to substance	ISO	6	26,931,969	26,937,789	RGD:6480464	CTD
G	Pou2af1	POU class 2 associating factor 1		decreases expression	ISO	8	54,534,417	54,561,348	RGD:6480464	CTD
G	Pou2f1	POU class 2 homeobox 1		increases expression	ISO	13	81,607,326	81,739,958	RGD:6480464	CTD
G	Pou5f1	POU class 5 homeobox 1		increases expression	ISO				RGD:6480464	CTD
G	Ppan	peter pan homolog (Drosophila)		increases expression	ISO	8	19,909,814	19,915,460	RGD:6480464	CTD
G	Ppp2r3a	protein phosphatase 2, regulatory subunit B'', alpha		increases expression	ISO	8	106,061,334	106,155,090	RGD:6480464	CTD
G	Ppp2r5d	protein phosphatase 2, regulatory subunit B', delta		decreases expression	ISO	9	10,054,005	10,078,501	RGD:6480464	CTD
G	Prkaa2	protein kinase, AMP-activated, alpha 2 catalytic subunit		multiple interactions	ISO	5	126,007,672	126,074,012	RGD:6480464	CTD
G	Prkar2b	protein kinase, cAMP dependent regulatory, type II beta		increases expression	ISO	6	50,234,979	50,325,298	RGD:6480464	CTD
G	Prkca	protein kinase C, alpha		increases activity	ISO	10	97,367,196	97,638,910	RGD:6480464	CTD
G	Prkca	protein kinase C, alpha		increases expression	EXP	10	97,367,196	97,638,910	RGD:6480464	CTD
G	Prkce	protein kinase C, epsilon		increases expression	EXP	6	9,631,234	10,097,311	RGD:6480464	CTD
G	Prkcz	protein kinase C, zeta		increases activity	ISO	5	172,061,825	172,172,793	RGD:6480464	CTD
G	Prkcz	protein kinase C, zeta		multiple interactions	ISO	5	172,061,825	172,172,793	RGD:6480464	CTD
G	Psmb6	proteasome (prosome, macropain) subunit, beta type 6		decreases expression	ISO	10	57,370,397	57,372,704	RGD:6480464	CTD
G	Psmc4	proteasome (prosome, macropain) 26S subunit, ATPase, 4		decreases expression	ISO	1	83,151,149	83,159,464	RGD:6480464	CTD
G	Psmg1	proteasome (prosome, macropain) assembly chaperone 1		decreases expression	ISO	11	36,283,570	36,291,750	RGD:6480464	CTD
G	Ptafr	platelet-activating factor receptor		decreases expression	ISO	5	152,565,687	152,587,342	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases activity	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptx3	pentraxin 3, long		decreases expression	ISO	2	156,089,917	156,095,726	RGD:6480464	CTD
G	Qk	quaking		increases expression	ISO	1	44,922,562	45,025,572	RGD:6480464	CTD
G	Rasa3	RAS p21 protein activator 3		multiple interactions	ISO	16	80,710,463	80,824,220	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		multiple interactions	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		multiple interactions	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		multiple interactions	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		multiple interactions	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		decreases expression	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		increases expression	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		increases phosphorylation	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		increases phosphorylation	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rbbp4	retinoblastoma binding protein 4		multiple interactions	ISO	5	148,472,397	148,492,172	RGD:6480464	CTD
G	Rbbp6	retinoblastoma binding protein 6		multiple interactions	ISO	1	181,818,248	181,849,942	RGD:6480464	CTD
G	Rbbp6	retinoblastoma binding protein 6		decreases expression	ISO	1	181,818,248	181,849,942	RGD:6480464	CTD
G	Rbbp6	retinoblastoma binding protein 6		increases expression	ISO	1	181,818,248	181,849,942	RGD:6480464	CTD
G	Rbbp9	retinoblastoma binding protein 9		increases expression	ISO	3	133,091,157	133,097,910	RGD:6480464	CTD
G	Rbck1	RanBP-type and C3HC4-type zinc finger containing 1		decreases expression	ISO	3	142,644,156	142,660,799	RGD:6480464	CTD
G	Rbfox3	RNA binding protein, fox-1 homolog (C. elegans) 3		increases expression	ISO	10	108,492,172	108,635,296	RGD:6480464	CTD
G	Rbl1	retinoblastoma-like 1 (p107)		multiple interactions	ISO	3	147,734,622	147,796,630	RGD:6480464	CTD
G	Rbl2	retinoblastoma-like 2		multiple interactions	ISO	19	17,045,131	17,092,597	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		decreases expression	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rgs1	regulator of G-protein signaling 1		increases expression	ISO	13	58,121,188	58,125,514	RGD:6480464	CTD
G	Rgs2	regulator of G-protein signaling 2		increases expression	ISO	13	57,891,849	57,894,452	RGD:6480464	CTD
G	Rhob	ras homolog family member B		increases expression	ISO	6	32,052,333	32,054,507	RGD:6480464	CTD
G	Rlbp1	retinaldehyde binding protein 1		increases expression	ISO	1	135,122,063	135,135,420	RGD:6480464	CTD
G	Rnf145	ring finger protein 145		decreases expression	ISO	10	29,680,833	29,720,064	RGD:6480464	CTD
G	Rpl5l1	ribosomal protein L5-like 1		multiple interactions	ISO	9	113,233,164	113,234,057	RGD:6480464	CTD
G	Rpl7a	ribosomal protein L7a		decreases expression	ISO	18	5,807,901	5,810,543	RGD:6480464	CTD
G	Rps25	ribosomal protein s25		increases expression	ISO	8	47,374,303	47,376,679	RGD:6480464	CTD
G	Rptor	regulatory associated protein of MTOR, complex 1		affects response to substance	ISO	10	109,000,666	109,302,700	RGD:6480464	CTD
G	Runx1t1	runt-related transcription factor 1; translocated to, 1 (cyclin D-related)		decreases expression	ISO	5	28,230,322	28,338,441	RGD:6480464	CTD
G	S100a10	S100 calcium binding protein A10		decreases expression	ISO	2	186,645,674	186,654,321	RGD:6480464	CTD
G	S1pr1	sphingosine-1-phosphate receptor 1		decreases expression	ISO	2	211,851,304	211,855,511	RGD:6480464	CTD
G	Sap30l	SAP30-like		decreases expression	ISO	10	43,396,414	43,404,655	RGD:6480464	CTD
G	Sc5d	sterol-C5-desaturase		increases expression	ISO	8	45,229,976	45,238,924	RGD:6480464	CTD
G	Scd1	stearoyl-Coenzyme A desaturase 1		increases expression	ISO	1	249,458,860	249,471,460	RGD:6480464	CTD
G	Serpine1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1		increases expression	ISO	12	20,931,996	20,942,374	RGD:6480464	CTD
G	Sfpq	splicing factor proline/glutamine-rich		increases expression	ISO	5	146,460,306	146,469,289	RGD:6480464	CTD
G	Sgk1	serum/glucocorticoid regulated kinase 1		increases expression	ISO	1	23,501,257	23,506,651	RGD:6480464	CTD
G	Sgpp1	sphingosine-1-phosphate phosphatase 1		decreases expression	ISO	6	98,306,168	98,327,175	RGD:6480464	CTD
G	Sirt1	sirtuin 1		multiple interactions	ISO	20	25,675,302	25,686,494	RGD:6480464	CTD
G	Slc19a1	solute carrier family 19 (folate transporter), member 1		decreases expression	ISO	20	11,984,283	12,001,865	RGD:6480464	CTD
G	Slc5a7	solute carrier family 5 (choline transporter), member 7		multiple interactions	EXP	9	133,838	165,943	RGD:6480464	CTD
G	Slc6a3	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3		multiple interactions	ISO	1	30,516,568	30,557,540	RGD:6480464	CTD
G	Smad9	SMAD family member 9		increases expression	ISO	2	144,014,436	144,030,672	RGD:6480464	CTD
G	Snai2	snail family zinc finger 2		decreases expression	EXP				RGD:6480464	CTD
G	Snca	synuclein, alpha (non A4 component of amyloid precursor)		increases expression	ISO	4	89,613,731	89,722,807	RGD:6480464	CTD
G	Snrk	SNF related kinase		decreases expression	ISO	8	121,958,351	121,968,989	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		decreases expression	ISO	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		increases expression	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sox18	SRY (sex determining region Y)-box 18		decreases expression	ISO	3	170,820,460	170,822,262	RGD:6480464	CTD
G	Src	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)		multiple interactions	ISO	3	148,157,256	148,170,524	RGD:6480464	CTD
G	Src	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)		increases phosphorylation	ISO	3	148,157,256	148,170,524	RGD:6480464	CTD
G	Src	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)		multiple interactions	ISO	3	148,157,256	148,170,524	RGD:6480464	CTD
G	Srebf1	sterol regulatory element binding transcription factor 1		decreases expression	ISO	10	46,461,684	46,483,646	RGD:6480464	CTD
G	Srgap2	SLIT-ROBO Rho GTPase activating protein 2		decreases expression	ISO	13	44,239,946	44,452,446	RGD:6480464	CTD
G	Sst	somatostatin		decreases expression	ISO	11	79,125,031	79,126,216	RGD:6480464	CTD
G	Star	steroidogenic acute regulatory protein		decreases expression	EXP	16	70,642,580	70,647,203	RGD:6480464	CTD
G	Star	steroidogenic acute regulatory protein		multiple interactions	EXP	16	70,642,580	70,647,203	RGD:6480464	CTD
G	Stat2	signal transducer and activator of transcription 2		decreases expression	ISO	7	1,564,385	1,580,652	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		increases activity	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		increases phosphorylation	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat5b	signal transducer and activator of transcription 5B		increases expression	ISO	10	89,716,624	89,743,134	RGD:6480464	CTD
G	Stat6	signal transducer and activator of transcription 6, interleukin-4 induced		increases expression	ISO	7	67,623,534	67,642,283	RGD:6480464	CTD
G	Stk25	serine/threonine kinase 25		increases expression	ISO	9	92,907,764	92,919,903	RGD:6480464	CTD
G	Sub1	SUB1 homolog (S. cerevisiae)		increases expression	ISO	2	61,418,076	61,430,139	RGD:6480464	CTD
G	Supt4h1	suppressor of Ty 4 homolog 1 (S. cerevisiae)		decreases expression	ISO	10	76,030,806	76,036,988	RGD:6480464	CTD
G	Tex264	testis expressed 264		decreases expression	ISO	8	111,852,793	111,879,691	RGD:6480464	CTD
G	Th	tyrosine hydroxylase		multiple interactions	ISO	1	203,164,253	203,171,506	RGD:6480464	CTD
G	Th	tyrosine hydroxylase		increases expression	ISO	1	203,164,253	203,171,506	RGD:6480464	CTD
G	Timp4	tissue inhibitor of metalloproteinase 4		affects expression	ISO	4	151,375,072	151,381,591	RGD:6480464	CTD
G	Tiparp	TCDD-inducible poly(ADP-ribose) polymerase		increases expression	ISO	2	155,312,341	155,339,357	RGD:6480464	CTD
G	Tjp1	tight junction protein 1		decreases expression	ISO	1	119,684,774	119,750,532	RGD:6480464	CTD
G	Tjp1	tight junction protein 1		decreases expression	EXP	1	119,684,774	119,750,532	RGD:6480464	CTD
G	Tjp1	tight junction protein 1		multiple interactions	EXP	1	119,684,774	119,750,532	RGD:6480464	CTD
G	Tmem97	transmembrane protein 97		increases expression	ISO	10	64,652,641	64,661,724	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases degradation	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnfrsf1a	tumor necrosis factor receptor superfamily, member 1a		increases expression	EXP	4	162,172,563	162,185,252	RGD:6480464	CTD
G	Tnfrsf1a	tumor necrosis factor receptor superfamily, member 1a		decreases expression	ISO	4	162,172,563	162,185,252	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		decreases expression	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		increases expression	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		decreases expression	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		affects expression	EXP	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		increases expression	EXP	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		affects response to substance	EXP	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		decreases expression	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Trpv1	transient receptor potential cation channel, subfamily V, member 1		increases activity	EXP	10	60,109,656	60,134,939	RGD:6480464	CTD
G	Trpv1	transient receptor potential cation channel, subfamily V, member 1		affects response to substance	EXP	10	60,109,656	60,134,939	RGD:6480464	CTD
G	Tshr	thyroid stimulating hormone receptor		increases expression	ISO	6	115,024,999	115,162,531	RGD:6480464	CTD
G	Tspo	translocator protein		multiple interactions	ISO	7	121,597,084	121,599,342	RGD:6480464	CTD
G	Txnip	thioredoxin interacting protein		increases expression	ISO	2	191,356,954	191,360,757	RGD:6480464	CTD
G	Uba2	ubiquitin-like modifier activating enzyme 2		multiple interactions	ISO	1	86,605,412	86,633,144	RGD:6480464	CTD
G	Uba2	ubiquitin-like modifier activating enzyme 2		increases expression	ISO	1	86,605,412	86,633,144	RGD:6480464	CTD
G	Ube2i	ubiquitin-conjugating enzyme E2I		decreases expression	ISO	10	14,509,948	14,524,551	RGD:6480464	CTD
G	Ugp2	UDP-glucose pyrophosphorylase 2		increases expression	ISO	14	102,072,724	102,113,561	RGD:6480464	CTD
G	Ugt1a2	UDP glucuronosyltransferase 1 family, polypeptide A2		increases glucuronidation	ISO	9	87,081,132	87,098,362	RGD:6480464	CTD
G	Ugt1a8	UDP glycosyltransferase 1 family, polypeptide A8		increases glucuronidation	ISO	9	87,017,029	87,098,362	RGD:6480464	CTD
G	Ugt1a9	UDP glucuronosyltransferase 1 family, polypeptide A9		increases glucuronidation	ISO	9	86,986,915	87,098,362	RGD:6480464	CTD
G	Uqcrfs1	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1		decreases expression	ISO	17	40,429,806	40,434,083	RGD:6480464	CTD
G	Uri1	URI1, prefoldin-like chaperone		increases expression	ISO	1	90,430,169	90,490,153	RGD:6480464	CTD
G	Vamp4	vesicle-associated membrane protein 4		increases expression	ISO	13	78,247,189	78,269,770	RGD:6480464	CTD
G	Vcam1	vascular cell adhesion molecule 1		increases expression	ISO	2	212,277,654	212,297,376	RGD:6480464	CTD
G	Vcam1	vascular cell adhesion molecule 1		increases expression	ISO	2	212,277,654	212,297,376	RGD:6480464	CTD
G	Xiap	X-linked inhibitor of apoptosis		increases expression	ISO	X	3,011,520	3,047,798	RGD:6480464	CTD
G	Xiap	X-linked inhibitor of apoptosis		increases expression	ISO	X	3,011,520	3,047,798	RGD:6480464	CTD
G	Xiap	X-linked inhibitor of apoptosis		multiple interactions	ISO	X	3,011,520	3,047,798	RGD:6480464	CTD
G	Yipf4	Yip1 domain family, member 4		decreases expression	ISO	6	20,885,521	20,896,940	RGD:6480464	CTD
G	Zcchc7	zinc finger, CCHC domain containing 7		increases expression	ISO	5	61,263,753	61,478,276	RGD:6480464	CTD
G	Zfp36	zinc finger protein 36		multiple interactions	ISO	1	83,486,643	83,489,123	RGD:6480464	CTD
G	Zfp36	zinc finger protein 36		increases activity	ISO	1	83,486,643	83,489,123	RGD:6480464	CTD
G	Zfp42	zinc finger protein 42		increases expression	ISO	16	52,150,048	52,158,306	RGD:6480464	CTD
G	Zfp42	zinc finger protein 42		multiple interactions	ISO	16	52,150,048	52,158,306	RGD:6480464	CTD
G	Znrf1	zinc and ring finger 1, E3 ubiquitin protein ligase		decreases expression	ISO	19	41,455,386	41,537,955	RGD:6480464	CTD
fosinopril
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases expression	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Bmpr2	bone morphogenetic protein receptor, type II (serine/threonine kinase)		multiple interactions	EXP	9	58,327,587	58,436,057	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		affects expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Pde1a	phosphodiesterase 1A, calmodulin-dependent		affects expression	EXP	3	62,650,092	62,928,487	RGD:6480464	CTD
G	Pde1c	phosphodiesterase 1C		affects expression	EXP	4	84,936,642	85,448,339	RGD:6480464	CTD
G	Slc15a1	solute carrier family 15 (oligopeptide transporter), member 1		multiple interactions	ISO	15	106,549,586	106,592,594	RGD:6480464	CTD
G	Slc15a2	solute carrier family 15 (H+/peptide transporter), member 2		multiple interactions	EXP	11	65,819,551	65,849,924	RGD:6480464	CTD
kainic acid
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb1b	ATP-binding cassette, subfamily B (MDR/TAP), member 1B		increases expression	EXP	4	21,829,489	21,912,239	RGD:6480464	CTD
G	Abcg2	ATP-binding cassette, subfamily G (WHITE), member 2		increases expression	ISO	4	87,502,584	87,560,017	RGD:6480464	CTD
G	Aco2	aconitase 2, mitochondrial		multiple interactions	EXP	7	120,223,788	120,266,944	RGD:6480464	CTD
G	Aco2	aconitase 2, mitochondrial		decreases activity	EXP	7	120,223,788	120,266,944	RGD:6480464	CTD
G	Adk	adenosine kinase		increases expression	ISO	15	3,071,412	3,458,891	RGD:6480464	CTD
G	Adnp	activity-dependent neuroprotector homeobox		multiple interactions	EXP	3	159,345,280	159,355,067	RGD:6480464	CTD
G	Adnp	activity-dependent neuroprotector homeobox		decreases expression	EXP	3	159,345,280	159,355,067	RGD:6480464	CTD
G	Adra1b	adrenoceptor alpha 1B		increases response to substance	ISO	10	28,889,092	28,946,889	RGD:6480464	CTD
G	Aifm1	apoptosis-inducing factor, mitochondrion-associated 1		increases localization	ISO	X	134,868,878	134,908,166	RGD:6480464	CTD
G	Aifm1	apoptosis-inducing factor, mitochondrion-associated 1		multiple interactions	ISO	X	134,868,878	134,908,166	RGD:6480464	CTD
G	Alox12e	arachidonate 12-lipoxygenase, epidermal		increases expression	ISO	10	57,159,920	57,167,385	RGD:6480464	CTD
G	Alox5ap	arachidonate 5-lipoxygenase activating protein		increases expression	EXP	12	6,245,808	6,269,796	RGD:6480464	CTD
G	Apaf1	apoptotic peptidase activating factor 1		increases expression	ISO	7	27,932,908	28,020,533	RGD:6480464	CTD
G	Apex1	APEX nuclease (multifunctional DNA repair enzyme) 1		multiple interactions	EXP	15	26,904,124	26,906,224	RGD:6480464	CTD
G	Apoe	apolipoprotein E		decreases expression	ISO	1	79,003,634	79,006,387	RGD:6480464	CTD
G	B4galt2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2		decreases expression	ISO	5	138,338,706	138,347,177	RGD:6480464	CTD
G	Bag3	Bcl2-associated athanogene 3		increases expression	EXP	1	187,781,147	187,804,835	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		multiple interactions	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	Bdnf	brain-derived neurotrophic factor		increases expression	EXP				RGD:6480464	CTD
G	C1qb	complement component 1, q subcomponent, B chain		increases expression	ISO	5	155,647,524	155,653,074	RGD:6480464	CTD
G	C4b	complement component 4B (Chido blood group)		increases expression	ISO	20	4,300,687	4,315,882	RGD:6480464	CTD
G	Calb1	calbindin 1		decreases expression	ISO	5	30,455,665	30,480,122	RGD:6480464	CTD
G	Camk4	calcium/calmodulin-dependent protein kinase IV		decreases expression	ISO	18	25,404,123	25,625,785	RGD:6480464	CTD
G	Capns1	calpain, small subunit 1		increases expression	EXP	1	85,519,568	85,525,929	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases expression	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Cck	cholecystokinin		decreases expression	EXP	8	126,492,636	126,499,220	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		increases expression	EXP	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Ccne1	cyclin E1		increases expression	EXP	1	90,568,189	90,577,426	RGD:6480464	CTD
G	Cd68	Cd68 molecule		increases expression	EXP	10	56,481,701	56,483,580	RGD:6480464	CTD
G	Cdc42	cell division cycle 42 (GTP binding protein)		increases expression	EXP	5	156,106,123	156,143,040	RGD:6480464	CTD
G	Cdh13	cadherin 13		increases expression	ISO	19	48,507,173	49,575,123	RGD:6480464	CTD
G	Cdk2	cyclin dependent kinase 2		increases expression	EXP	7	2,000,196	2,007,682	RGD:6480464	CTD
G	Ceacam1	carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)		increases expression	ISO	1	80,742,540	80,758,943	RGD:6480464	CTD
G	Chgb	chromogranin B (secretogranin 1)		increases expression	EXP	3	120,571,736	120,584,874	RGD:6480464	CTD
G	Cited2	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2		increases expression	EXP	1	12,721,500	12,723,943	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		increases expression	EXP	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cnrip1	cannabinoid receptor interacting protein 1		increases expression	EXP	14	97,908,407	97,937,729	RGD:6480464	CTD
G	Col1a1	collagen, type I, alpha 1		increases expression	ISO	10	83,622,438	83,639,368	RGD:6480464	CTD
G	Crhr1	corticotropin releasing hormone receptor 1		increases expression	EXP	10	93,312,405	93,354,229	RGD:6480464	CTD
G	Ctss	cathepsin S		increases expression	ISO	2	190,425,290	190,466,877	RGD:6480464	CTD
G	Ctsz	cathepsin Z		increases expression	ISO				RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		increases localization	ISO	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		multiple interactions	ISO	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		increases expression	EXP	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Dgcr6	DiGeorge syndrome critical region gene 6		decreases expression	ISO	11	84,922,649	84,927,694	RGD:6480464	CTD
G	Dhx36	DEAH (Asp-Glu-Ala-His) box polypeptide 36		increases expression	ISO	2	152,122,767	152,161,219	RGD:6480464	CTD
G	Diablo	diablo, IAP-binding mitochondrial protein		increases expression	EXP	12	34,196,347	34,209,633	RGD:6480464	CTD
G	Drd2	dopamine receptor D2		decreases response to substance	ISO	8	52,641,160	52,707,749	RGD:6480464	CTD
G	Egr1	early growth response 1		decreases expression	ISO	18	27,343,919	27,346,117	RGD:6480464	CTD
G	Egr1	early growth response 1		affects expression	EXP	18	27,343,919	27,346,117	RGD:6480464	CTD
G	Emc3	ER membrane protein complex subunit 3		decreases expression	ISO	4	149,405,742	149,422,064	RGD:6480464	CTD
G	En2	engrailed homeobox 2		affects response to substance	ISO	4	2,469,889	2,475,729	RGD:6480464	CTD
G	En2	engrailed homeobox 2		decreases expression	ISO	4	2,469,889	2,475,729	RGD:6480464	CTD
G	Enc1	ectodermal-neural cortex 1		decreases expression	ISO	2	27,720,805	27,733,168	RGD:6480464	CTD
G	Etfb	electron-transfer-flavoprotein, beta polypeptide		decreases expression	ISO	1	93,820,124	93,834,288	RGD:6480464	CTD
G	Fbxw5	F-box and WD repeat domain containing 5		decreases expression	ISO	3	3,673,918	3,677,876	RGD:6480464	CTD
G	Fgf2	fibroblast growth factor 2		increases expression	EXP	2	123,893,314	123,947,136	RGD:6480464	CTD
G	Fgf5	fibroblast growth factor 5		increases expression	EXP	14	12,713,971	12,734,634	RGD:6480464	CTD
G	Fgfr1	Fibroblast growth factor receptor 1		increases expression	EXP	16	70,869,974	70,910,045	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	ISO	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	ISO	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		decreases expression	ISO	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fosl2	fos-like antigen 2		increases expression	EXP				RGD:6480464	CTD
G	Fxyd1	FXYD domain-containing ion transport regulator 1		decreases expression	ISO	1	86,095,551	86,098,079	RGD:6480464	CTD
G	Gad1	glutamate decarboxylase 1		increases expression	EXP	3	52,789,370	52,830,038	RGD:6480464	CTD
G	Gad2	glutamate decarboxylase 2		increases expression	EXP	17	96,259,430	96,321,857	RGD:6480464	CTD
G	Gadd45a	growth arrest and DNA-damage-inducible, alpha		increases expression	EXP	4	96,649,941	96,652,243	RGD:6480464	CTD
G	Gadd45b	growth arrest and DNA-damage-inducible, beta		decreases expression	ISO	7	10,289,073	10,291,102	RGD:6480464	CTD
G	Gadd45g	growth arrest and DNA-damage-inducible, gamma		decreases expression	ISO	17	19,230,896	19,232,641	RGD:6480464	CTD
G	Gap43	growth associated protein 43		multiple interactions	EXP	11	59,989,085	60,083,971	RGD:6480464	CTD
G	Gap43	growth associated protein 43		increases expression	EXP	11	59,989,085	60,083,971	RGD:6480464	CTD
G	Gcnt2	glucosaminyl (N-acetyl) transferase 2, I-branching enzyme		increases expression	ISO	17	29,767,383	29,808,950	RGD:6480464	CTD
G	Gfap	glial fibrillary acidic protein		increases expression	ISO	10	92,059,881	92,068,555	RGD:6480464	CTD
G	Gfap	glial fibrillary acidic protein		increases expression	EXP	10	92,059,881	92,068,555	RGD:6480464	CTD
G	Gfap	glial fibrillary acidic protein		increases expression	ISO	10	92,059,881	92,068,555	RGD:6480464	CTD
G	Gfap	glial fibrillary acidic protein		multiple interactions	ISO	10	92,059,881	92,068,555	RGD:6480464	CTD
G	Gfap	glial fibrillary acidic protein		increases expression	EXP	10	92,059,881	92,068,555	RGD:6480464	CTD
G	Gria1	glutamate receptor, ionotropic, AMPA 1		multiple interactions	EXP	10	42,613,359	42,616,610	RGD:6480464	CTD
G	Gria1	glutamate receptor, ionotropic, AMPA 1		decreases expression	EXP	10	42,613,359	42,616,610	RGD:6480464	CTD
G	Gria1	glutamate receptor, ionotropic, AMPA 1		multiple interactions	EXP	10	42,613,359	42,616,610	RGD:6480464	CTD
G	Gria1	glutamate receptor, ionotropic, AMPA 1		decreases expression	EXP	10	42,613,359	42,616,610	RGD:6480464	CTD
G	Gria1	glutamate receptor, ionotropic, AMPA 1		multiple interactions	ISO	10	42,613,359	42,616,610	RGD:6480464	CTD
G	Gria1	glutamate receptor, ionotropic, AMPA 1		decreases expression	ISO	10	42,613,359	42,616,610	RGD:6480464	CTD
G	Gria2	glutamate receptor, ionotropic, AMPA 2		multiple interactions	EXP	2	172,265,155	172,385,285	RGD:6480464	CTD
G	Gria2	glutamate receptor, ionotropic, AMPA 2		affects response to substance	ISO	2	172,265,155	172,385,285	RGD:6480464	CTD
G	Gria2	glutamate receptor, ionotropic, AMPA 2		decreases expression	EXP	2	172,265,155	172,385,285	RGD:6480464	CTD
G	Gria2	glutamate receptor, ionotropic, AMPA 2		multiple interactions	ISO	2	172,265,155	172,385,285	RGD:6480464	CTD
G	Gria2	glutamate receptor, ionotropic, AMPA 2		decreases expression	ISO	2	172,265,155	172,385,285	RGD:6480464	CTD
G	Gria3	glutamate receptor, ionotropic, AMPA 3		decreases expression	EXP	X	3,452,523	3,718,486	RGD:6480464	CTD
G	Gria3	glutamate receptor, ionotropic, AMPA 3		increases expression	EXP	X	3,452,523	3,718,486	RGD:6480464	CTD
G	Gria3	glutamate receptor, ionotropic, AMPA 3		decreases expression	ISO	X	3,452,523	3,718,486	RGD:6480464	CTD
G	Gria3	glutamate receptor, ionotropic, AMPA 3		multiple interactions	ISO	X	3,452,523	3,718,486	RGD:6480464	CTD
G	Gria4	glutamate receptor, ionotropic, AMPA 4		decreases expression	ISO	8	956,325	1,438,314	RGD:6480464	CTD
G	Gria4	glutamate receptor, ionotropic, AMPA 4		multiple interactions	ISO	8	956,325	1,438,314	RGD:6480464	CTD
G	Grik1	glutamate receptor, ionotropic, kainate 1		multiple interactions	ISO	11	27,703,874	28,106,450	RGD:6480464	CTD
G	Grik1	glutamate receptor, ionotropic, kainate 1		decreases expression	ISO	11	27,703,874	28,106,450	RGD:6480464	CTD
G	Grik2	glutamate receptor, ionotropic, kainate 2		increases expression	ISO	20	53,231,473	53,713,131	RGD:6480464	CTD
G	Grik2	glutamate receptor, ionotropic, kainate 2		multiple interactions	ISO	20	53,231,473	53,713,131	RGD:6480464	CTD
G	Grik3	glutamate receptor, ionotropic, kainate 3		decreases expression	ISO	5	144,842,374	145,058,047	RGD:6480464	CTD
G	Grik3	glutamate receptor, ionotropic, kainate 3		multiple interactions	ISO	5	144,842,374	145,058,047	RGD:6480464	CTD
G	Grik4	glutamate receptor, ionotropic, kainate 4		multiple interactions	ISO	8	45,510,258	45,681,279	RGD:6480464	CTD
G	Grik4	glutamate receptor, ionotropic, kainate 4		decreases expression	ISO	8	45,510,258	45,681,279	RGD:6480464	CTD
G	Grik5	glutamate receptor, ionotropic, kainate 5		multiple interactions	ISO	1	80,313,801	80,384,390	RGD:6480464	CTD
G	Grik5	glutamate receptor, ionotropic, kainate 5		decreases expression	ISO	1	80,313,801	80,384,390	RGD:6480464	CTD
G	Grin1	glutamate receptor, ionotropic, N-methyl D-aspartate 1		multiple interactions	ISO	3	3,453,784	3,480,381	RGD:6480464	CTD
G	Grin1	glutamate receptor, ionotropic, N-methyl D-aspartate 1		decreases expression	ISO	3	3,453,784	3,480,381	RGD:6480464	CTD
G	Grin2a	glutamate receptor, ionotropic, N-methyl D-aspartate 2A		decreases expression	ISO	10	5,588,229	6,004,780	RGD:6480464	CTD
G	Grin2a	glutamate receptor, ionotropic, N-methyl D-aspartate 2A		multiple interactions	ISO	10	5,588,229	6,004,780	RGD:6480464	CTD
G	Grin2b	glutamate receptor, ionotropic, N-methyl D-aspartate 2B		multiple interactions	ISO	4	172,721,895	173,183,187	RGD:6480464	CTD
G	Grin2b	glutamate receptor, ionotropic, N-methyl D-aspartate 2B		decreases expression	ISO	4	172,721,895	173,183,187	RGD:6480464	CTD
G	Grin2c	glutamate receptor, ionotropic, N-methyl D-aspartate 2C		decreases expression	ISO	10	105,323,371	105,340,976	RGD:6480464	CTD
G	Grin2c	glutamate receptor, ionotropic, N-methyl D-aspartate 2C		multiple interactions	ISO	10	105,323,371	105,340,976	RGD:6480464	CTD
G	Grin2d	glutamate receptor, ionotropic, N-methyl D-aspartate 2D		decreases expression	ISO	1	96,308,548	96,345,931	RGD:6480464	CTD
G	Grin2d	glutamate receptor, ionotropic, N-methyl D-aspartate 2D		multiple interactions	ISO	1	96,308,548	96,345,931	RGD:6480464	CTD
G	Grin3a	glutamate receptor, ionotropic, N-methyl-D-aspartate 3A		multiple interactions	ISO	5	66,406,451	66,602,353	RGD:6480464	CTD
G	Grin3a	glutamate receptor, ionotropic, N-methyl-D-aspartate 3A		decreases expression	ISO	5	66,406,451	66,602,353	RGD:6480464	CTD
G	Grin3b	glutamate receptor, ionotropic, N-methyl-D-aspartate 3B		decreases expression	ISO	7	11,243,973	11,250,311	RGD:6480464	CTD
G	Grin3b	glutamate receptor, ionotropic, N-methyl-D-aspartate 3B		multiple interactions	ISO	7	11,243,973	11,250,311	RGD:6480464	CTD
G	Gsk3b	glycogen synthase kinase 3 beta		decreases activity	ISO	11	64,284,731	64,428,698	RGD:6480464	CTD
G	Homer1	homer homolog 1 (Drosophila)		increases expression	EXP				RGD:6480464	CTD
G	Hpca	hippocalcin		decreases response to substance	ISO	5	148,267,898	148,276,223	RGD:6480464	CTD
G	Hsd11b1	hydroxysteroid 11-beta dehydrogenase 1		decreases expression	ISO	13	109,063,491	109,089,468	RGD:6480464	CTD
G	Hspa1a	heat shock protein 1A		multiple interactions	ISO	20	3,945,716	3,959,552	RGD:6480464	CTD
G	Hspa1a	heat shock protein 1A		multiple interactions	ISO	20	3,945,716	3,959,552	RGD:6480464	CTD
G	Idi1	isopentenyl-diphosphate delta isomerase 1		decreases expression	ISO	17	72,557,196	72,563,149	RGD:6480464	CTD
G	Il10	interleukin 10		decreases expression	EXP	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il12a	interleukin 12A		affects response to substance	ISO	2	158,710,261	158,717,689	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases secretion	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases expression	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il6	interleukin 6		increases response to substance	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		increases expression	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Itgam	integrin, alpha M		increases expression	ISO	1	187,334,413	187,385,583	RGD:6480464	CTD
G	Jagn1	jagunal homolog 1 (Drosophila)		decreases expression	ISO				RGD:6480464	CTD
G	Jun	jun proto-oncogene		multiple interactions	EXP	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Jun	jun proto-oncogene		multiple interactions	EXP	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Jun	jun proto-oncogene		increases expression	EXP	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Jun	jun proto-oncogene		increases expression	EXP	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Junb	jun B proto-oncogene		decreases expression	ISO	19	24,831,536	24,833,320	RGD:6480464	CTD
G	Junb	jun B proto-oncogene		increases expression	EXP	19	24,831,536	24,833,320	RGD:6480464	CTD
G	Kalrn	kalirin, RhoGEF kinase		increases expression	EXP	11	68,124,348	68,611,336	RGD:6480464	CTD
G	Kif20a	kinesin family member 20A		decreases expression	ISO	18	27,100,044	27,108,530	RGD:6480464	CTD
G	Klf10	Kruppel-like factor 10		decreases expression	ISO	7	73,821,190	73,826,866	RGD:6480464	CTD
G	Kng1	kininogen 1		multiple interactions	EXP	11	80,109,499	80,131,887	RGD:6480464	CTD
G	Kras	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog		increases expression	EXP	4	182,869,242	182,895,106	RGD:6480464	CTD
G	Lep	leptin		decreases response to substance	ISO	4	55,943,837	55,945,938	RGD:6480464	CTD
G	Lmo1	LIM domain only 1		decreases expression	ISO	1	166,706,025	166,741,550	RGD:6480464	CTD
G	Map2	microtubule-associated protein 2		multiple interactions	ISO	9	65,174,376	65,256,003	RGD:6480464	CTD
G	Map2	microtubule-associated protein 2		increases expression	ISO	9	65,174,376	65,256,003	RGD:6480464	CTD
G	Map3k5	mitogen-activated protein kinase kinase kinase 5		decreases expression	ISO	1	15,205,361	15,346,422	RGD:6480464	CTD
G	Map3k5	mitogen-activated protein kinase kinase kinase 5		decreases expression	ISO	1	15,205,361	15,346,422	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		increases expression	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mast3	microtubule associated serine/threonine kinase 3		decreases expression	ISO	16	19,155,246	19,169,436	RGD:6480464	CTD
G	Mpdz	multiple PDZ domain protein		affects response to substance	ISO	5	100,008,984	100,170,202	RGD:6480464	CTD
G	Mpeg1	macrophage expressed 1		increases expression	ISO	1	215,387,912	215,390,172	RGD:6480464	CTD
G	Msmo1	methylsterol monooxygenase 1		decreases expression	ISO	16	26,698,324	26,716,247	RGD:6480464	CTD
G	Mt1a	metallothionein 1a		decreases response to substance	ISO	19	11,261,631	11,262,647	RGD:6480464	CTD
G	Mt1a	metallothionein 1a		increases expression	EXP	19	11,261,631	11,262,647	RGD:6480464	CTD
G	Mt2A	metallothionein 2A		increases expression	EXP	19	11,267,811	11,268,585	RGD:6480464	CTD
G	Mt2A	metallothionein 2A		decreases response to substance	ISO	19	11,267,811	11,268,585	RGD:6480464	CTD
G	Mt3	metallothionein 3		decreases expression	EXP	19	11,284,554	11,286,402	RGD:6480464	CTD
G	Mt3	metallothionein 3		increases expression	EXP	19	11,284,554	11,286,402	RGD:6480464	CTD
G	Myo5b	myosin Vb		decreases expression	ISO	18	71,381,068	71,580,824	RGD:6480464	CTD
G	Myo9a	myosin IXA		increases expression	ISO	8	63,578,001	63,783,813	RGD:6480464	CTD
G	Ncam1	neural cell adhesion molecule 1		decreases expression	EXP	8	52,822,350	53,120,572	RGD:6480464	CTD
G	Nfe2l2	nuclear factor, erythroid derived 2, like 2		affects localization	ISO	3	58,366,693	58,394,116	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		multiple interactions	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		decreases expression	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		increases expression	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Npy	neuropeptide Y		decreases response to substance	ISO	4	78,038,013	78,045,187	RGD:6480464	CTD
G	Npy	neuropeptide Y		increases expression	EXP	4	78,038,013	78,045,187	RGD:6480464	CTD
G	Npy	neuropeptide Y		multiple interactions	EXP	4	78,038,013	78,045,187	RGD:6480464	CTD
G	Nr4a1	nuclear receptor subfamily 4, group A, member 1		decreases expression	ISO	7	140,012,807	140,020,590	RGD:6480464	CTD
G	Nr4a1	nuclear receptor subfamily 4, group A, member 1		increases expression	EXP	7	140,012,807	140,020,590	RGD:6480464	CTD
G	Nr4a2	nuclear receptor subfamily 4, group A, member 2		increases expression	EXP	3	38,866,205	38,871,678	RGD:6480464	CTD
G	Nr4a3	nuclear receptor subfamily 4, group A, member 3		increases expression	EXP	5	64,713,468	64,753,311	RGD:6480464	CTD
G	Nrp2	neuropilin 2		affects response to substance	ISO	9	61,348,529	61,460,457	RGD:6480464	CTD
G	Ntn1	netrin 1		increases expression	EXP	10	54,950,521	55,133,536	RGD:6480464	CTD
G	Ntrk2	neurotrophic tyrosine kinase, receptor, type 2		increases expression	EXP	17	11,494,463	11,811,654	RGD:6480464	CTD
G	Nudcd2	NudC domain containing 2		increases expression	ISO	10	25,763,129	25,768,887	RGD:6480464	CTD
G	Nudt4	nudix (nucleoside diphosphate linked moiety X)-type motif 4		increases expression	ISO	7	32,753,728	32,769,953	RGD:6480464	CTD
G	Otx2	orthodenticle homeobox 2		decreases expression	EXP	15	24,622,851	24,632,435	RGD:6480464	CTD
G	Pak3	p21 protein (Cdc42/Rac)-activated kinase 3		decreases expression	EXP	X	34,734,814	34,842,093	RGD:6480464	CTD
G	Pdyn	prodynorphin		multiple interactions	EXP	3	117,291,025	117,303,367	RGD:6480464	CTD
G	Pdyn	prodynorphin		increases expression	EXP	3	117,291,025	117,303,367	RGD:6480464	CTD
G	Penk	proenkephalin		multiple interactions	EXP	5	17,509,323	17,514,265	RGD:6480464	CTD
G	Penk	proenkephalin		increases expression	EXP	5	17,509,323	17,514,265	RGD:6480464	CTD
G	Penk	proenkephalin		increases expression	EXP	5	17,509,323	17,514,265	RGD:6480464	CTD
G	Penk	proenkephalin		multiple interactions	EXP	5	17,509,323	17,514,265	RGD:6480464	CTD
G	Penk	proenkephalin		increases expression	EXP	5	17,509,323	17,514,265	RGD:6480464	CTD
G	Pick1	protein interacting with PRKCA 1		decreases expression	ISO	7	117,213,299	117,232,651	RGD:6480464	CTD
G	Pkp2	plakophilin 2		decreases expression	ISO	11	86,553,493	86,584,425	RGD:6480464	CTD
G	Plod3	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3		decreases expression	ISO	12	20,856,527	20,867,088	RGD:6480464	CTD
G	Ppif	peptidylprolyl isomerase F		increases response to substance	ISO	16	1,292,835	1,299,556	RGD:6480464	CTD
G	Ppp1r9b	protein phosphatase 1, regulatory subunit 9B		increases expression	EXP	10	83,674,797	83,690,639	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases response to substance	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		decreases response to substance	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Qk	quaking		increases expression	ISO	1	44,922,562	45,025,572	RGD:6480464	CTD
G	Rac1	ras-related C3 botulinum toxin substrate 1		increases expression	EXP	12	11,380,314	11,400,531	RGD:6480464	CTD
G	Rad23a	RAD23 homolog A (S. cerevisiae)		increases expression	EXP	19	24,971,070	24,976,901	RGD:6480464	CTD
G	Rasd1	RAS, dexamethasone-induced 1		decreases expression	ISO	10	46,291,401	46,293,130	RGD:6480464	CTD
G	Rbfox1	RNA binding protein, fox-1 homolog (C. elegans) 1		increases response to substance	ISO	10	8,213,474	8,561,580	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		increases expression	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rgs16	regulator of G-protein signaling 16		decreases expression	ISO	13	68,807,863	68,811,307	RGD:6480464	CTD
G	Rhoa	ras homolog family member A		increases expression	EXP				RGD:6480464	CTD
G	S1pr1	sphingosine-1-phosphate receptor 1		decreases expression	ISO	2	211,851,304	211,855,511	RGD:6480464	CTD
G	Sap30l	SAP30-like		decreases expression	ISO	10	43,396,414	43,404,655	RGD:6480464	CTD
G	Sema4d	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D		increases expression	EXP	17	19,352,632	19,373,179	RGD:6480464	CTD
G	Serpine1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1		increases expression	ISO	12	20,931,996	20,942,374	RGD:6480464	CTD
G	Serpine1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1		multiple interactions	ISO	12	20,931,996	20,942,374	RGD:6480464	CTD
G	Sfpq	splicing factor proline/glutamine-rich		increases expression	ISO	5	146,460,306	146,469,289	RGD:6480464	CTD
G	Slc11a2	solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2		increases expression	EXP	7	139,094,505	139,127,427	RGD:6480464	CTD
G	Slc1a1	solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1		decreases expression	ISO	1	232,469,746	232,549,584	RGD:6480464	CTD
G	Slc1a2	solute carrier family 1 (glial high affinity glutamate transporter), member 2		multiple interactions	ISO	3	87,870,558	87,992,401	RGD:6480464	CTD
G	Slc6a2	solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2		increases response to substance	ISO	19	15,098,281	15,139,898	RGD:6480464	CTD
G	Slc8a3	solute carrier family 8 (sodium/calcium exchanger), member 3		multiple interactions	EXP	6	105,012,888	105,159,942	RGD:6480464	CTD
G	Slc8a3	solute carrier family 8 (sodium/calcium exchanger), member 3		increases cleavage	EXP	6	105,012,888	105,159,942	RGD:6480464	CTD
G	Snrk	SNF related kinase		decreases expression	ISO	8	121,958,351	121,968,989	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		decreases expression	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		increases expression	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sptan1	spectrin, alpha, non-erythrocytic 1		increases expression	EXP	3	8,956,380	9,021,831	RGD:6480464	CTD
G	Sst	somatostatin		decreases expression	ISO	11	79,125,031	79,126,216	RGD:6480464	CTD
G	Tac1	tachykinin, precursor 1		decreases expression	EXP	4	32,649,666	32,657,632	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases expression	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tp53	tumor protein p53		increases expression	EXP	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Trh	thyrotropin releasing hormone		decreases expression	EXP	4	126,425,212	126,427,670	RGD:6480464	CTD
G	Trh	thyrotropin releasing hormone		increases expression	EXP	4	126,425,212	126,427,670	RGD:6480464	CTD
G	Trhr	thyrotropin releasing hormone receptor		decreases expression	EXP	7	80,050,671	80,095,991	RGD:6480464	CTD
G	Tyrobp	Tyro protein tyrosine kinase binding protein		increases expression	ISO	1	85,365,371	85,369,224	RGD:6480464	CTD
G	Uchl1	ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)		increases expression	EXP	14	44,114,392	44,124,947	RGD:6480464	CTD
G	Uhmk1	U2AF homology motif (UHM) kinase 1		decreases expression	ISO	13	86,010,861	86,025,965	RGD:6480464	CTD
G	Uri1	URI1, prefoldin-like chaperone		increases expression	ISO	1	90,430,169	90,490,153	RGD:6480464	CTD
G	Utp3	UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae)		decreases expression	ISO	14	21,095,959	21,097,613	RGD:6480464	CTD
G	Vamp7	vesicle-associated membrane protein 7		decreases expression	EXP	12	17,248,700	17,278,193	RGD:6480464	CTD
G	Vegfa	vascular endothelial growth factor A		decreases expression	ISO	9	10,520,730	10,536,071	RGD:6480464	CTD
G	Wfs1	Wolfram syndrome 1 (wolframin)		increases expression	ISO	14	79,379,680	79,404,003	RGD:6480464	CTD
G	Xpa	xeroderma pigmentosum, complementation group A		increases expression	EXP	5	62,706,719	62,750,771	RGD:6480464	CTD
G	Zcchc7	zinc finger, CCHC domain containing 7		increases expression	ISO	5	61,263,753	61,478,276	RGD:6480464	CTD
lisinopril dihydrate
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ache	acetylcholinesterase		multiple interactions	ISO				RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases expression	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		increases expression	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		affects response to substance	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Cd2ap	CD2-associated protein		multiple interactions	EXP	9	13,827,015	13,888,338	RGD:6480464	CTD
G	Edn1	endothelin 1		decreases secretion	ISO	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Gh1	growth hormone 1		multiple interactions	EXP	10	95,692,240	95,694,117	RGD:6480464	CTD
G	Havcr1	hepatitis A virus cellular receptor 1		multiple interactions	EXP	10	31,834,519	31,858,019	RGD:6480464	CTD
G	Hpse	heparanase		multiple interactions	EXP	14	10,144,322	10,185,115	RGD:6480464	CTD
G	Igfbp1	insulin-like growth factor binding protein 1		increases expression	ISO	14	87,950,222	87,955,289	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		multiple interactions	EXP	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mpo	myeloperoxidase		multiple interactions	ISO	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nphs1	nephrosis 1, congenital, Finnish type (nephrin)		multiple interactions	EXP	1	85,414,492	85,444,233	RGD:6480464	CTD
G	Nphs1	nephrosis 1, congenital, Finnish type (nephrin)		multiple interactions	EXP	1	85,414,492	85,444,233	RGD:6480464	CTD
G	Nphs2	nephrosis 2, idiopathic, steroid-resistant		multiple interactions	EXP	13	71,296,482	71,308,868	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		decreases expression	ISO	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Ren	renin		increases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		increases expression	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Timp1	TIMP metallopeptidase inhibitor 1		multiple interactions	EXP	X	12,542,496	12,547,094	RGD:6480464	CTD
G	Vegfa	vascular endothelial growth factor A		multiple interactions	EXP	9	10,520,730	10,536,071	RGD:6480464	CTD

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	501881
chemical entity	501881
atom	500845
nonmetal atom	459609
nitrogen atom	174049
nitrogen molecular entity	174049
organonitrogen compound	154428
organonitrogen heterocyclic compound	82119
pyrrolidines	1979
(5-tert-butyl-1,3,4-oxadiazol-2-yl)[(2R)-pyrrolidin-2-yl]methanone	0
1-(2-hydroxyethyl)pyrrolidinium +	0
1-(5-oxo-2,3,5,9b-tetrahydro-1H-pyrrolo[2,1-a]isoindol-9-yl)-3-(5-pyrrolidin-2-yl-1H-pyrazol-3-yl)urea	0
5-chloro-6-\{[(2Z)-2-iminopyrrolidin-1-yl]methyl\}uracil	0
FR901469	0
N-(2,4-dinitrophenyl)-L-proline	0
N-(2,4-dinitrophenyl)proline	0
N-(\{(2S,4R)-4-[(4-chlorobenzyl)oxy]pyrrolidin-2-yl\}methyl)isoquinoline-5-sulfonamide	0
N-acylpyrrolidine +	1
N-alkylpyrrolidine +	1494
N-benzyl-2-(2,6-dimethylphenoxy)-N-[((3R,4S)-4-\{[isobutyl(phenylsulfonyl)amino]methyl\}pyrrolidin-3-yl)methyl]acetamide	0
allyl \{(1S)-1-[(5-\{4-[(2,3-dihydro-1H-inden-2-ylamino)carbonyl]benzyl\}-1,2,4-oxadiazol-3-yl)carbonyl]-3-pyrrolidin-3-ylpropyl\}carbamate	0
aminopyrrolidine +	0
amisulpride	0
bepridil +	11
clemizole	0
darifenacin +	3
epolamine	0
fluoropyrrolidine +	0
hydroxypyrrolidine +	95
methyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate	0
methyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate	0
methyl 5-(hydroxymethyl)pyrrolidine-2-carboxylate	0
methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate	0
miboplatin	0
procyclidine +	0
proline +	22
proline derivative +	283
prolinols +	0
pyrrolidin-2-ylmethylamine +	0
pyrrolidine	2
pyrrolidine N-oxide +	0
pyrrolidine alkaloid +	1434
pyrrolidinecarbaldehyde +	0
pyrrolidinecarbohydrazide +	0
pyrrolidinecarbonitrile +	0
pyrrolidinecarboxamide +	1
pyrrolidinecarboxylic acid +	276
pyrrolidinehydroxamic acid +	0
pyrrolidinesulfonic acid +	0
pyrrolidinium ion +	1
pyrrolidinone +	84
pyrrolidinoquinazoline +	0
rolicyclidine	0
Path 2
Term	Annotations
CHEBI ontology	501881
subatomic particle	500845
composite particle	500845
hadron	500845
baryon	500845
nucleon	500845
atomic nucleus	500845
atom	500845
main group element atom	470301
p-block element atom	467779
carbon group element atom	419149
carbon atom	415667
organic molecular entity	415660
organic molecule	365810
organic cyclic compound	304492
organic heterocyclic compound	158510